Ensemble learning of foundation models for precision oncology

📅 2025-08-22
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Current pathology foundation models suffer from weak generalizability and inconsistent performance due to heterogeneous training strategies and datasets, hindering unified clinical deployment in precision oncology. To address this, we propose ELF—a novel ensemble framework for whole-slide images (WSIs)—the first multi-foundation-model integration method tailored to WSI analysis. ELF fuses representations from five state-of-the-art models to generate robust, unified WSI-level embeddings. By aggregating complementary cross-model information and modeling features at the sliding-window level, ELF overcomes contextual fragmentation inherent in conventional tile-level analysis. Evaluated across 20 anatomical sites and over 50,000 WSIs, ELF significantly outperforms all individual foundation models and existing sliding-level approaches on disease classification, biomarker detection, and treatment response prediction—particularly demonstrating superior generalizability in data-scarce settings.

Technology Category

Application Category

📝 Abstract
Histopathology is essential for disease diagnosis and treatment decision-making. Recent advances in artificial intelligence (AI) have enabled the development of pathology foundation models that learn rich visual representations from large-scale whole-slide images (WSIs). However, existing models are often trained on disparate datasets using varying strategies, leading to inconsistent performance and limited generalizability. Here, we introduce ELF (Ensemble Learning of Foundation models), a novel framework that integrates five state-of-the-art pathology foundation models to generate unified slide-level representations. Trained on 53,699 WSIs spanning 20 anatomical sites, ELF leverages ensemble learning to capture complementary information from diverse models while maintaining high data efficiency. Unlike traditional tile-level models, ELF's slide-level architecture is particularly advantageous in clinical contexts where data are limited, such as therapeutic response prediction. We evaluated ELF across a wide range of clinical applications, including disease classification, biomarker detection, and response prediction to major anticancer therapies, cytotoxic chemotherapy, targeted therapy, and immunotherapy, across multiple cancer types. ELF consistently outperformed all constituent foundation models and existing slide-level models, demonstrating superior accuracy and robustness. Our results highlight the power of ensemble learning for pathology foundation models and suggest ELF as a scalable and generalizable solution for advancing AI-assisted precision oncology.
Problem

Research questions and friction points this paper is trying to address.

Integrating disparate pathology foundation models for consistent performance
Improving generalizability of AI models across diverse cancer types
Enhancing clinical decision-making with limited histopathology data
Innovation

Methods, ideas, or system contributions that make the work stand out.

Ensemble learning integrates multiple pathology foundation models
Generates unified slide-level representations from diverse data
Superior accuracy in clinical oncology applications
🔎 Similar Papers
No similar papers found.
Xiangde Luo
Xiangde Luo
Stanford University
medical image analysiscomputer visioncomputational pathology
X
Xiyue Wang
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
Feyisope Eweje
Feyisope Eweje
Perelman School of Medicine, University of Pennsylvania
Medical devicesArtificial intelligence
X
Xiaoming Zhang
Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
S
Sen Yang
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
R
Ryan Quinton
Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, CA, USA
Jinxi Xiang
Jinxi Xiang
Tsinghua University; Tencent AI Lab; Stanford University
Computer VisionMedical Image Analysis
Y
Yuchen Li
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
Yuanfeng Ji
Yuanfeng Ji
Stanford; HKU
Computer visionMedical Image Analysis
Z
Zhe Li
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
Y
Yijiang Chen
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
C
Colin Bergstrom
Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, CA, USA
T
Ted Kim
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
F
Francesca Maria Olguin
Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, CA, USA
K
Kelley Yuan
Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
M
Matthew Abikenari
Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA
A
Andrew Heider
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
S
Sierra Willens
Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, CA, USA
S
Sanjeeth Rajaram
Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, CA, USA
R
Robert West
Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
J
Joel Neal
Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, CA, USA
Maximilian Diehn
Maximilian Diehn
Stanford University
Liquid biopsiescirculating tumor DNAcancer genomicsbiomarkersradiation biology
Ruijiang Li
Ruijiang Li
Stanford University
biomarkercancer imagingRadiomicsmachine learning